Status
Conditions
Treatments
About
To comparing the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.
Full description
The aim of this study is to compare the stage-for-stage prognosis of patients with cardia and non-cardia gastric cancer after operation.In this study, patients with cardiac and non-cardiac gastric cancer who undergo radical resection from January 2019 to December 2024 will be included. We will follow up the patient's progression, recurrence time and survival time.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Histopathology or cytopathology proven cardia or non-cardia gastric cancer;
Operable gastric cancer patients: primary lesions can be completely excision, no distant metastasis;
Life expectancy of at least 6 months;
ECOG(Eastern Cooperative Oncology Group ) score 0-1;
Age: 18~80 years old;
Normal hemodynamic indices before the recruitment (including blood cell count and liver/kidney function).
For example: WBC(White blood cell count )>4.0×109/L; NEU(Neutrophils)>1.5×109/L; PLT(Platelet)>100×109/L;
Roughly normal cardiopulmonary function: No coronary heart disease, myocardial infarction, pulmonary heart disease, refractory hypertension;
Not concomitant with other uncontrollable benign diseases before the recruitment;
Voluntarily signed the informed consent.
Exclusion criteria
1,000 participants in 2 patient groups
Loading...
Central trial contact
Jiuda Zhao, M.D.
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal